Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 1/2015

01-01-2015 | Rhinology

First experiences with an individual nasal olive in patients with hereditary haemorrhagic telangiectasia (HHT)

Authors: Basel Al Kadah, George Papaspyrou, Mathias Schneider, Bernhard Schick

Published in: European Archives of Oto-Rhino-Laryngology | Issue 1/2015

Login to get access

Abstract

Hereditary haemorrhagic teleangiectasia (HHT) is most notably characterized by vulnerable vascular formations of the nasal superficial mucosa. Epistaxis is one of the most common symptoms of the afflicted patients, with an incidence of more than 90 %. A variable series of treatments have been described, ranging from nasal ointments to the complete surgical occlusion of the nose. The objective of this pilot study is the presentation of first experiences in treating patients suffering from HHT and chronically recurrent epistaxis with an individual nasal olive made from silicone. Eleven patients (six men, five women) aging from 44 to 80 years with known HHT were treated at the ENT department of Homburg/Saar between October 2008 and July 2012 because of nasal bleeding by Nd:YAG laser or argon plasma coagulation. After the surgical treatment, an imprint of the nasal aditus was taken to manufacture an individual custom-made silicone nasal olive. Patients were wearing the nasal olive for 3–8 h a day. Check-ups were made every 6 months. Epistaxis severity score (ESS) was used pre- and post-nasal olive application. The observation period was 12–48 months. The utilization of the silicone nasal olive led to a distinct reduction of epistaxis events. Apart from the nasal olive, our patients needed no further treatment of the nose during the observation period except for a nasal ointment. Insertion and removal of the nasal olive were handled by the patients themselves. The local manipulation in handling the nasal olive caused no epistaxis itself. A significant improvement of the ESS and satisfaction was reported in all patients. Use of an individually manufactured silicone nasal olive is a promising extension to the established treatments of epistaxis in HHT patients. Tolerance towards this treatment by the patients was high due to the low personal burden and encumbrance. The extended use of the presented method in HHT patients may be beneficial. However, a more prolonged observation period is necessary in the future to judge the long-term efficiency of individual nasal olives.
Literature
1.
go back to reference Rendu M (1896) Épistaxis répétées chez un sujet porteur de petits angiomes cutanés et muqueux. Bull Mém Soc Méd Hôp Paris 13:731–733 Rendu M (1896) Épistaxis répétées chez un sujet porteur de petits angiomes cutanés et muqueux. Bull Mém Soc Méd Hôp Paris 13:731–733
2.
go back to reference Osler W (1901) On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Johns Hopkins Hops Bull 12:333–337 Osler W (1901) On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Johns Hopkins Hops Bull 12:333–337
3.
go back to reference Weber FP (1907) Multiple hereditary developmental angiomata (telangiectases) of the skin and mucous membranes associated with recurring haemorrhages. Lancet 2:160–162 Weber FP (1907) Multiple hereditary developmental angiomata (telangiectases) of the skin and mucous membranes associated with recurring haemorrhages. Lancet 2:160–162
4.
go back to reference Hanes FM (1907) Multiple hereditary telangiectases cause hemorrhage (hereditary hemorrhagic telangiectasia). Johns Hopkins Hosp Bull 20:63–73 Hanes FM (1907) Multiple hereditary telangiectases cause hemorrhage (hereditary hemorrhagic telangiectasia). Johns Hopkins Hosp Bull 20:63–73
5.
go back to reference Parkin JL, Dixon JA (1985) Argon laser treatment of head and neck vascular lesions. Otolaryngol Head Neck Surg 93:211–216PubMed Parkin JL, Dixon JA (1985) Argon laser treatment of head and neck vascular lesions. Otolaryngol Head Neck Surg 93:211–216PubMed
6.
go back to reference Shapsay SM (1984) Oliver P treatment of hereditary hemorrhagic telangiectasia by Nd-YAG laser photocoagulation. Laryngoscope 94:1554–1556 Shapsay SM (1984) Oliver P treatment of hereditary hemorrhagic telangiectasia by Nd-YAG laser photocoagulation. Laryngoscope 94:1554–1556
7.
go back to reference Werner JA, Lippert BM, Geisthoff UW, Rudert H (1997) Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasia. Laryngorhinootologie 76:495–501 (Article in German)PubMedCrossRef Werner JA, Lippert BM, Geisthoff UW, Rudert H (1997) Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasia. Laryngorhinootologie 76:495–501 (Article in German)PubMedCrossRef
8.
go back to reference Shah RK, Dhingra JK, Shapshay SM (2002) Hereditary hemorrhagic telangiectasia: a review of 76 cases. Laryngoscope 112:767–773PubMedCrossRef Shah RK, Dhingra JK, Shapshay SM (2002) Hereditary hemorrhagic telangiectasia: a review of 76 cases. Laryngoscope 112:767–773PubMedCrossRef
9.
go back to reference Byahatti SV, Rebeiz EE, Shapshay SM (1997) Hereditary hemorrhagic telangiectasia: what the otolaryngologist should know. Am J Rhinol 11:55–62PubMedCrossRef Byahatti SV, Rebeiz EE, Shapshay SM (1997) Hereditary hemorrhagic telangiectasia: what the otolaryngologist should know. Am J Rhinol 11:55–62PubMedCrossRef
10.
go back to reference Vickery CL, Kuhn FA (1996) Using the KTP/532 laser to control epistaxis in patients with hereditary hemorrhagic telangiectasia. South Med J 89:78–80PubMedCrossRef Vickery CL, Kuhn FA (1996) Using the KTP/532 laser to control epistaxis in patients with hereditary hemorrhagic telangiectasia. South Med J 89:78–80PubMedCrossRef
11.
go back to reference Karapantzos I, Tsimpiris N, Goulis DG, Van Hoecke H, Van Cauwenberge P, Danielides V (2005) Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:yAG laser and quality of life assessment using the HR-QoL questionnaire. Eur Arch Otorhinolaryngol 262:830–833 (Epub 2005 Mar 1)PubMedCrossRef Karapantzos I, Tsimpiris N, Goulis DG, Van Hoecke H, Van Cauwenberge P, Danielides V (2005) Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:yAG laser and quality of life assessment using the HR-QoL questionnaire. Eur Arch Otorhinolaryngol 262:830–833 (Epub 2005 Mar 1)PubMedCrossRef
12.
go back to reference Kardos TB, Holt T, Ferguson MM (1989) Histological evaluation of the effect of a miniature carbon dioxide laser on oral mucosa. Int J Oral Maxillofac Surg 18:117–120PubMedCrossRef Kardos TB, Holt T, Ferguson MM (1989) Histological evaluation of the effect of a miniature carbon dioxide laser on oral mucosa. Int J Oral Maxillofac Surg 18:117–120PubMedCrossRef
13.
go back to reference Bergler W, Götte K, Riedel F, Back W, Hörmann K (1998) Argon plasma coagulation in treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa. HNO 46:228–232 (Article in German)PubMedCrossRef Bergler W, Götte K, Riedel F, Back W, Hörmann K (1998) Argon plasma coagulation in treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa. HNO 46:228–232 (Article in German)PubMedCrossRef
14.
go back to reference Saunders WH (1960) Septal dermoplasty for control of nosebleeds caused by hereditary hemorrhagic telangiectasia or septal perforations. Trans Am Acad Ophthalmol Otolaryngol 64:500–506PubMed Saunders WH (1960) Septal dermoplasty for control of nosebleeds caused by hereditary hemorrhagic telangiectasia or septal perforations. Trans Am Acad Ophthalmol Otolaryngol 64:500–506PubMed
15.
go back to reference McCaffrey TV, Kern EB, Lake CF (1977) Management of epistaxis in hereditary hemorrhagic telangiectasia. Review of 80 cases. Arch Otolaryngol 103:627–630PubMedCrossRef McCaffrey TV, Kern EB, Lake CF (1977) Management of epistaxis in hereditary hemorrhagic telangiectasia. Review of 80 cases. Arch Otolaryngol 103:627–630PubMedCrossRef
16.
go back to reference Fiorella ML, Ross D, Henderson KJ, White RI Jr (2005) Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Laryngoscope 115:301–305PubMedCrossRef Fiorella ML, Ross D, Henderson KJ, White RI Jr (2005) Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Laryngoscope 115:301–305PubMedCrossRef
17.
go back to reference Levine CG, Ross DA, Henderson KJ, Leder SB, White RI Jr (2008) Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 138:721–724PubMedCrossRef Levine CG, Ross DA, Henderson KJ, Leder SB, White RI Jr (2008) Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 138:721–724PubMedCrossRef
18.
19.
go back to reference Brooker DS, Cinnamond MJ (1991) Young’s procedure in the treatment of epistaxis. J Laryngol Otol 105:847–848PubMedCrossRef Brooker DS, Cinnamond MJ (1991) Young’s procedure in the treatment of epistaxis. J Laryngol Otol 105:847–848PubMedCrossRef
20.
go back to reference Gluckman JL, Portugal LG (1994) Modified Young’s procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia. Laryngoscope 104:1174–1177PubMedCrossRef Gluckman JL, Portugal LG (1994) Modified Young’s procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia. Laryngoscope 104:1174–1177PubMedCrossRef
21.
go back to reference Lund V, Howard DJ (1997) Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia. J Laryngology and Otology J Laryngol Otol 111:30–33 Lund V, Howard DJ (1997) Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia. J Laryngology and Otology J Laryngol Otol 111:30–33
22.
go back to reference Pau H, Carney AS, Murty GE (2001) Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): otorhinolaryngological manifestations. Clin Otolaryngol Allied Sci 26:93–98PubMedCrossRef Pau H, Carney AS, Murty GE (2001) Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): otorhinolaryngological manifestations. Clin Otolaryngol Allied Sci 26:93–98PubMedCrossRef
23.
go back to reference Strother CM, Newton TH (1976) Percutaneous embolization to control epistaxis in Rendu-Osler-Weber disease. Arch Otolaryngol 102:58–60PubMedCrossRef Strother CM, Newton TH (1976) Percutaneous embolization to control epistaxis in Rendu-Osler-Weber disease. Arch Otolaryngol 102:58–60PubMedCrossRef
24.
go back to reference Weissman JL, Jungreis CA, Johnson JT (1995) Therapeutic embolization for control of epistaxis in a patient with hereditary hemorrhagic telangiectasia. Am J Otolaryngol 16:138–140PubMedCrossRef Weissman JL, Jungreis CA, Johnson JT (1995) Therapeutic embolization for control of epistaxis in a patient with hereditary hemorrhagic telangiectasia. Am J Otolaryngol 16:138–140PubMedCrossRef
25.
go back to reference Harrison DFN (1982) Use of estrogen in treatment of familiar hemorrhagic teleangiectasia. Laryngoscope 92:314–319PubMedCrossRef Harrison DFN (1982) Use of estrogen in treatment of familiar hemorrhagic teleangiectasia. Laryngoscope 92:314–319PubMedCrossRef
26.
go back to reference Sadick H, Riedel F, Oulmi J, Hörmann K, Bergler WF (2003) Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa. HNO 51:118–124 (Article in German)PubMedCrossRef Sadick H, Riedel F, Oulmi J, Hörmann K, Bergler WF (2003) Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa. HNO 51:118–124 (Article in German)PubMedCrossRef
27.
go back to reference Vase P (1981) Estrogen treatment of hereditary hemorrhagic telangiectasia. A double-blind controlled clinical trial. Acta Med Scand 209:393–396PubMedCrossRef Vase P (1981) Estrogen treatment of hereditary hemorrhagic telangiectasia. A double-blind controlled clinical trial. Acta Med Scand 209:393–396PubMedCrossRef
28.
go back to reference Pizzi G, Turcato G, Polico R, Busetto M, Antonello M, Princivalli M (1995) Brachytherapy of epistaxis in Rendu-Osler disease. Indications, technic, results. Radiol Med 89:861–864 Article in ItalianPubMed Pizzi G, Turcato G, Polico R, Busetto M, Antonello M, Princivalli M (1995) Brachytherapy of epistaxis in Rendu-Osler disease. Indications, technic, results. Radiol Med 89:861–864 Article in ItalianPubMed
29.
go back to reference Folz BJ, Zoll B, Alfke H, Toussaint A, Maier RF, Werner JA (2006) Manifestations of hereditary hemorrhagic telangiectasia in children and adolescents. Eur Arch Otorhinolaryngol 263(1):53–61 Epub 2005 Jun 24PubMedCrossRef Folz BJ, Zoll B, Alfke H, Toussaint A, Maier RF, Werner JA (2006) Manifestations of hereditary hemorrhagic telangiectasia in children and adolescents. Eur Arch Otorhinolaryngol 263(1):53–61 Epub 2005 Jun 24PubMedCrossRef
30.
go back to reference Folz BJ, Wollstein AC, Alfke H, Dünne AA, Lippert BM, Görg K, Wagner HJ, Bien S, Werner JA (2004) The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study. Eur Arch Otorhinolaryngol 261(9):509–516 (Epub 2003 Dec 17)PubMedCrossRef Folz BJ, Wollstein AC, Alfke H, Dünne AA, Lippert BM, Görg K, Wagner HJ, Bien S, Werner JA (2004) The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study. Eur Arch Otorhinolaryngol 261(9):509–516 (Epub 2003 Dec 17)PubMedCrossRef
31.
go back to reference Dupuis-Girod S, Ginon I, Saurin JC, Marion D, Guillot E, Decullier E, Roux A, Carette MF, Gilbert-Dussardier B, Hatron PY, Lacombe P, Lorcerie B, Rivière S, Corre R, Giraud S, Bailly S, Paintaud G, Ternant D, Valette PJ, Plauchu H, Faure F (2012) Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA 307:948–955PubMedCrossRef Dupuis-Girod S, Ginon I, Saurin JC, Marion D, Guillot E, Decullier E, Roux A, Carette MF, Gilbert-Dussardier B, Hatron PY, Lacombe P, Lorcerie B, Rivière S, Corre R, Giraud S, Bailly S, Paintaud G, Ternant D, Valette PJ, Plauchu H, Faure F (2012) Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA 307:948–955PubMedCrossRef
32.
go back to reference Guldmann R, Dupret A, Nivoix Y, Schultz P, Debry C (2012) Bevacizumab nasal spray: noninvasive treatment of epistaxis in patients with Rendu-Osler disease. Laryngoscope 122:953–955PubMedCrossRef Guldmann R, Dupret A, Nivoix Y, Schultz P, Debry C (2012) Bevacizumab nasal spray: noninvasive treatment of epistaxis in patients with Rendu-Osler disease. Laryngoscope 122:953–955PubMedCrossRef
33.
go back to reference Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA (2010) An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope 120:838–843PubMedCrossRef Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA (2010) An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope 120:838–843PubMedCrossRef
34.
go back to reference Folz BJ, Lippert BM, Wollstein AC, Tennie J, Happle R, Werner JA (2004) Mucocutaneous telangiectases of the head and neck in individuals with hereditary hemorrhagic telangiectasia—analysis of distribution and symptoms. Eur J Dermatol. 14:407–411PubMed Folz BJ, Lippert BM, Wollstein AC, Tennie J, Happle R, Werner JA (2004) Mucocutaneous telangiectases of the head and neck in individuals with hereditary hemorrhagic telangiectasia—analysis of distribution and symptoms. Eur J Dermatol. 14:407–411PubMed
35.
go back to reference Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66–67PubMedCrossRef Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66–67PubMedCrossRef
36.
go back to reference Al Kadah B, Bumm K, Wolf G, Schneider M, Schick B (2011) A new innovative approach in treatment of hereditary haemorrhagic teleangiectasia (HHT): a nasal olive. GMS Curr Posters Otorhinolaryngol Head Neck Surg 7:Doc61 Al Kadah B, Bumm K, Wolf G, Schneider M, Schick B (2011) A new innovative approach in treatment of hereditary haemorrhagic teleangiectasia (HHT): a nasal olive. GMS Curr Posters Otorhinolaryngol Head Neck Surg 7:Doc61
37.
go back to reference Folz BJ, Chirtesiu AM, Konnerth CG (2013) Customized nasal breathing tubes as an alternative to Young’s procedure in HHT patients with epistaxis Preliminary results. Hematology Reports Volume 3(suppl 1):137 Folz BJ, Chirtesiu AM, Konnerth CG (2013) Customized nasal breathing tubes as an alternative to Young’s procedure in HHT patients with epistaxis Preliminary results. Hematology Reports Volume 3(suppl 1):137
Metadata
Title
First experiences with an individual nasal olive in patients with hereditary haemorrhagic telangiectasia (HHT)
Authors
Basel Al Kadah
George Papaspyrou
Mathias Schneider
Bernhard Schick
Publication date
01-01-2015
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 1/2015
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-014-3086-3

Other articles of this Issue 1/2015

European Archives of Oto-Rhino-Laryngology 1/2015 Go to the issue